US 10087232
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
granted A61KA61K36/81A61K38/00
Quick answer
US patent 10087232 (Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy) held by Protalix Ltd. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protalix Ltd.
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K36/81, A61K38/00, A61K9/0053, A61P